318 related articles for article (PubMed ID: 16774126)
1. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.
Hashimoto H; Arai T; Takeguchi A; Hioki K; Ohnishi Y; Kawai K; Ito M; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
Comp Med; 2006 Jun; 56(3):176-87. PubMed ID: 16774126
[TBL] [Abstract][Full Text] [Related]
2. Reconsideration of insulin signals induced by improved laboratory animal diets, Japanese and American diets, in IRS-2 deficient mice.
Hashimoto H; Arai T; Mori A; Kawai K; Hikishima K; Ohnishi Y; Eto T; Ito M; Hioki K; Suzuki R; Ohsugi M; Saito M; Ueyama Y; Okano H; Yamauchi T; Kubota N; Ueki K; Tobe K; Tamaoki N; Kadowaki T; Kosaka K
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):577-86. PubMed ID: 19629935
[TBL] [Abstract][Full Text] [Related]
3. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
Wang ZJ; Liu Q; Li PP; Zou CH; Shen ZF
Eur J Pharmacol; 2008 Feb; 580(1-2):277-83. PubMed ID: 18048028
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.
Kido Y; Burks DJ; Withers D; Bruning JC; Kahn CR; White MF; Accili D
J Clin Invest; 2000 Jan; 105(2):199-205. PubMed ID: 10642598
[TBL] [Abstract][Full Text] [Related]
5. Phenotypes of IRS-2 deficient mice produced by reproductive technology are stable.
Hashimoto H; Arai T; Ohnishi Y; Eto T; Ito M; Hioki K; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
Exp Anim; 2007 Apr; 56(2):149-54. PubMed ID: 17460360
[TBL] [Abstract][Full Text] [Related]
6. Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2.
Kim JJ; Kido Y; Scherer PE; White MF; Accili D
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1694-701. PubMed ID: 17299086
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
Bitar MS; Al-Saleh E; Al-Mulla F
Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
[TBL] [Abstract][Full Text] [Related]
8. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
9. Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice.
Yoshizumi S; Suzuki S; Hirai M; Hinokio Y; Yamada T; Yamada T; Tsunoda U; Aburatani H; Yamaguchi K; Miyagi T; Oka Y
Metabolism; 2007 Mar; 56(3):420-9. PubMed ID: 17292733
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice.
Kim JH; Stewart TP; Soltani-Bejnood M; Wang L; Fortuna JM; Mostafa OA; Moustaid-Moussa N; Shoieb AM; McEntee MF; Wang Y; Bechtel L; Naggert JK
J Endocrinol; 2006 Nov; 191(2):437-46. PubMed ID: 17088413
[TBL] [Abstract][Full Text] [Related]
11. IRS2 takes center stage in the development of type 2 diabetes.
Brady MJ
J Clin Invest; 2004 Oct; 114(7):886-8. PubMed ID: 15467824
[TBL] [Abstract][Full Text] [Related]
12. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.
Terauchi Y; Takamoto I; Kubota N; Matsui J; Suzuki R; Komeda K; Hara A; Toyoda Y; Miwa I; Aizawa S; Tsutsumi S; Tsubamoto Y; Hashimoto S; Eto K; Nakamura A; Noda M; Tobe K; Aburatani H; Nagai R; Kadowaki T
J Clin Invest; 2007 Jan; 117(1):246-57. PubMed ID: 17200721
[TBL] [Abstract][Full Text] [Related]
13. [Knockout mouse models for type 2 diabetes. Mice with insulin resistance].
Terauchi Y; Kadowaki T
Nihon Rinsho; 2002 Aug; 60 Suppl 8():64-9. PubMed ID: 12355825
[No Abstract] [Full Text] [Related]
14. Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.
Clough MH; Schneider DJ; Sobel BE; White MF; Wadsworth MP; Taatjes DJ
J Histochem Cytochem; 2005 May; 53(5):603-10. PubMed ID: 15872053
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
[TBL] [Abstract][Full Text] [Related]
16. Pdx1 restores beta cell function in Irs2 knockout mice.
Kushner JA; Ye J; Schubert M; Burks DJ; Dow MA; Flint CL; Dutta S; Wright CV; Montminy MR; White MF
J Clin Invest; 2002 May; 109(9):1193-201. PubMed ID: 11994408
[TBL] [Abstract][Full Text] [Related]
17. High-fructose diet preserves beta-cell mass and prevents diabetes in nonobese diabetic mice: A potential role for increased insulin receptor substrate-2 expression.
Orban T; Landaker E; Ruan Z; Cordeman TP; Weitgasser R; Bonner-Weir S; Jackson RA; Patti ME
Metabolism; 2001 Nov; 50(11):1369-76. PubMed ID: 11699059
[TBL] [Abstract][Full Text] [Related]
18. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
[TBL] [Abstract][Full Text] [Related]
19. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle.
Agarwal P; Srivastava R; Srivastava AK; Ali S; Datta M
Biochim Biophys Acta; 2013 Aug; 1832(8):1294-303. PubMed ID: 23579070
[TBL] [Abstract][Full Text] [Related]
20. Characterization of diabetes-related traits in MSM and JF1 mice on high-fat diet.
Kobayashi M; Ohno T; Tsuchiya T; Horio F
J Nutr Biochem; 2004 Oct; 15(10):614-21. PubMed ID: 15542353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
